Täby, Sweden

Martin Haraldsson

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Taby, SE (2010)
  • Stockholm, SE (2015 - 2016)
  • Täby, SE (2021 - 2023)

Company Filing History:


Years Active: 2010-2025

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: Martin Haraldsson: Innovator in Pharmaceutical Compounds

Introduction

Martin Haraldsson is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for therapeutic use. With a total of 7 patents to his name, Haraldsson's work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Among his latest patents, Haraldsson has developed compounds such as 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives. These compounds are useful in therapy for treating cancers, inflammation, autoimmune diseases, and graft-versus-host diseases, particularly in transplantation patients. Additionally, he has patented tetrahydroindazoles, which are intended for the treatment of cancer and the prevention of viral infections.

Career Highlights

Throughout his career, Martin Haraldsson has worked with esteemed organizations, including the Thomas Helledays Foundation for Medical Research and Proximagen Limited. His innovative research has positioned him as a key figure in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Haraldsson has collaborated with notable colleagues, including Lars Sandberg and Marianne Nilsson. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Martin Haraldsson's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through research and development. His patents reflect a dedication to finding effective treatments for serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…